Search research articles
Contact Us
Filters
Showing results (121-130 of 195) with videos related to
Page
of 20
Sort By:
Plant Science : an International Journal of Experimental Plant Biology
|
April 25, 2024
PagPXYs improve drought tolerance by regulating reactive oxygen species homeostasis in the cambium of Populus alba × P. glandulosa
Cheng Jiang, Jiawei Wang, Xinyue Fu, et al.
Cell Death & Disease
|
July 15, 2018
Inhibition of the miR-192/215-Rab11-FIP2 axis suppresses human gastric cancer progression
Xiaojing Zhang, Yin Peng, Yong Huang, et al.
Scientific Reports
|
February 13, 2024
A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer
Ying Cheng, Chunjiao Wu, Lin Wu, et al.
Annals of Hematology
|
January 1, 2018
Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia
Hongli Zhao, Yanqiu Zhao, Yingmei Zhang, et al.
BMC Medicine
|
January 8, 2023
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
Yuankai Shi, Jianying Zhou, Yanqiu Zhao, et al.
Marine Drugs
|
April 21, 2022
Pan-Genomic and Transcriptomic Analyses of Marine <i>Pseudoalteromonas agarivorans</i> Hao 2018 Revealed Its Genomic and Metabolic Features
Yuhao Jv, Chenxiang Xi, Yanqiu Zhao, et al.
Eclinicalmedicine
|
January 30, 2023
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)
Yuanyuan Zhao, Yunpeng Yang, Fangfang Gao, et al.
Blood
|
December 24, 2009
Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia
Jin Zhou, Yingmei Zhang, Jinmei Li, et al.
Journal for Immunotherapy of Cancer
|
August 19, 2023
Tislelizumab plus chemotherapy for patients with <i>EGFR</i>-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
Hua Zhong, Xueyan Zhang, Panwen Tian, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2025
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial
Xinyu Wu, Rui Wan, Lin Wu, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 195) with videos related to
Sort By:
Page
of 20
Plant Science : an International Journal of Experimental Plant Biology
|
April 25, 2024
PagPXYs improve drought tolerance by regulating reactive oxygen species homeostasis in the cambium of Populus alba × P. glandulosa
Cheng Jiang, Jiawei Wang, Xinyue Fu, et al.
Cell Death & Disease
|
July 15, 2018
Inhibition of the miR-192/215-Rab11-FIP2 axis suppresses human gastric cancer progression
Xiaojing Zhang, Yin Peng, Yong Huang, et al.
Scientific Reports
|
February 13, 2024
A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer
Ying Cheng, Chunjiao Wu, Lin Wu, et al.
Annals of Hematology
|
January 1, 2018
Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia
Hongli Zhao, Yanqiu Zhao, Yingmei Zhang, et al.
BMC Medicine
|
January 8, 2023
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
Yuankai Shi, Jianying Zhou, Yanqiu Zhao, et al.
Marine Drugs
|
April 21, 2022
Pan-Genomic and Transcriptomic Analyses of Marine <i>Pseudoalteromonas agarivorans</i> Hao 2018 Revealed Its Genomic and Metabolic Features
Yuhao Jv, Chenxiang Xi, Yanqiu Zhao, et al.
Eclinicalmedicine
|
January 30, 2023
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)
Yuanyuan Zhao, Yunpeng Yang, Fangfang Gao, et al.
Blood
|
December 24, 2009
Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia
Jin Zhou, Yingmei Zhang, Jinmei Li, et al.
Journal for Immunotherapy of Cancer
|
August 19, 2023
Tislelizumab plus chemotherapy for patients with <i>EGFR</i>-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
Hua Zhong, Xueyan Zhang, Panwen Tian, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2025
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial
Xinyu Wu, Rui Wan, Lin Wu, et al.
Page
of 20